Rigel Pharms
1 products tracked · names used in filings: Rigel Pharms
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 01 May 2026🇺🇸 FDA approval
FDA approves Veppanu (vepdegestrant), a new medicine
Rigel Pharms; NDA219835; New molecular entity; tablet · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Veppanu vepdegestrant | Approved | 2026-05-01 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.